首頁 > 市場調查報告書 > 製藥

再生醫學細胞療法

歐洲生物生產市場預測至 2030 年 - 區域分析 - 按產品、應用、設備和最終用戶

市場調查報告書

商品編碼

1510612

歐洲生物生產市場預測至 2030 年 - 區域分析 - 按產品、應用、設備和最終用戶

Europe Bioproduction Market Forecast to 2030 - Regional Analysis - by Product, Application, Equipment, and End User

出版日期: 2024年05月07日 | 出版商:

The Insight Partners | 英文 113 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

2022年歐洲生物生產市場價值為55.1506億美元，預計到2030年將達到147.898億美元；預計2022年至2030年複合年成長率為13.1%。

慢性病盛行率不斷上升推動歐洲生物生產市場

心血管疾病（CVD）、神經系統疾病、自體免疫疾病和癌症是全球造成死亡和殘疾率很高的慢性疾病。根據世界衛生組織 (WHO) 的數據，CVD 是全球第一大死因，估計每年奪去 1,790 萬人的生命。癌症也是全世界死亡的主要原因之一，影響著大量人口。因此，它給社會帶來了巨大的經濟負擔。據世界衛生組織稱，2020 年，全球約有 1,000 萬人死於癌症。然而，越來越多的關於開發有效治療疾病的研究正在積極影響市場的成長。基因療法和細胞療法正在改變癌症治療格局；例如，諾華公司的Kymriah用於治療瀰漫性大B細胞淋巴瘤。

此外，患者、專家、初級保健臨床醫生和其他醫療保健專業人員認知到生物相似藥是有效且安全的藥物，正在推動對生物相似藥的需求。此外，生物相似藥有助於改善數百萬患者的生活，同時每年為醫療保健系統節省數十億美元。它們是治療許多疾病的有效且具成本效益的選擇，包括慢性皮膚病和腸道疾病，如克隆氏症、牛皮癬、腸躁症和結腸炎；糖尿病;自體免疫疾病；癌症;腎臟狀況；和關節炎。

隨著慢性病盛行率的快速成長，用於治療危及生命的疾病的生物生產的需求在過去五年中迅速成長，從而推動了生物生產市場的發展。

歐洲生物生產市場概況

歐洲生物生產市場分為德國、英國、法國、義大利、西班牙和歐洲其他地區。歐洲在全球生物生產市場中佔據重要地位，預計 2022-2030 年複合年成長率顯著。慢性病盛行率的不斷上升導致產品上市和批准數量不斷增加，技術進步和投資也不斷增加，從而促進了該地區的市場成長。

生物相似藥引入了競爭並提高了生物製劑的可負擔性，最終提供節省成本和增值服務來支持患者護理和醫療保健行業。醫療保健專業人員可以以更低的成本使用高品質的生物製劑治療更多患者。由於節省成本的巨大潛力，德國衛生部推出了一項新法律來增加生物相似藥的採用。由於一些歐盟 (EU) 國家允許藥劑師取代生物相似藥，這將代表實踐中的重大變化，特別是對德國而言。此外，醫療保健提供者如德國法蘭克福的 PHI 骨科物理治療中心、德國國際診所； CBC Health 慕尼黑，德國；和其他提供者為各種慢性疾病提供幹細胞療法，如糖尿病視網膜病變、視神經神經炎和類風濕性關節炎。預計這將在未來幾年增加細胞療法的採用。此外，國際參與者之間越來越多的合作夥伴關係也促進了市場的成長。例如，2020 年 11 月，Hitachi Chemical Advanced Therapeutics Solutions, LLC 和 apceth Biopharma GmbH 擴大了與 Bluebird Bio 的關係，為多種療法的臨床和商業供應提供長期開發和製造服務協議，包括擴大在歐洲ZYNTEGLO 是一種治療輸血依賴性B 地中海型貧血(TDT) 的一次性基因療法。因此，隨著德國政府擴大採用生物相似藥，該市場預計將蓬勃發展。

歐洲生物生產市場收入及 2030 年預測（百萬美元）

歐洲生物生產市場細分

歐洲生物生產市場分為產品、應用、設備、最終用戶和國家。

根據產品，歐洲生物生產市場分為生物製劑和生物相似藥、疫苗、細胞和基因療法、核酸療法等。到 2022 年，生物製劑和生物相似藥領域將佔據歐洲最大的生物生產市場。

在應用方面，歐洲生物生產市場分為類風濕性關節炎、血液疾病、癌症、糖尿病、心血管疾病等。到 2022 年，癌症領域將佔據歐洲最大的生物生產市場。

依設備分類，歐洲生物生產市場分為上游設備、下游設備、生物反應器、耗材及配件。到 2022 年，消耗品和配件領域將佔據歐洲最大的生物生產市場。

就最終用戶而言，歐洲生物生產市場分為生物製藥公司、合約製造組織等。到 2022 年，生物製藥公司領域將佔據歐洲最大的生物生產市場。

依國家/地區分類，歐洲生物生產市場分為德國、英國、法國、義大利、西班牙和歐洲其他地區。 2022 年，德國在歐洲生物生產市場佔有率中佔據主導地位。

Lonza Group AG、bbi-biotech GmbH、Danaher Corp、Sartorius AG、FUJIFILM Irvine Scientific Inc、Thermo Fisher Scientific Inc、Merck KGaA、F. Hoffmann-La Roche Ltd 和 Bio-Rad Laboratories Inc. 是營運中的一些領先公司在歐洲生物生產市場。

Cardiovascular diseases (CVDs), neurological disorders, autoimmune disorders, and cancer are among the chronic diseases causing death and disabilities at a significant rate worldwide. As per the World Health Organization (WHO), CVDs are the number 1 cause of death globally, taking an estimated 17.9 million lives each year. Cancer is also among the leading causes of mortality worldwide, affecting a huge population; therefore, it acts as a huge financial burden on society. According to the WHO, in 2020, ~10 million deaths occurred due to cancer globally. However, growing research on developing effective treatments for the disease is positively affecting the market growth. Gene therapy and cell therapy are transforming the cancer treatment landscape; for example, Novartis' Kymriah is used to treat diffuse large B-cell lymphoma.

Moreover, recognition of biosimilars as efficacious and safe agents by patients, specialists, primary care clinicians, and other healthcare professionals is propelling the demand for biosimilars. In addition, biosimilars help improve life of millions of patients while saving billions of dollars of the healthcare system per year. They are effective and cost-effective options in treating many diseases, including chronic skin conditions and bowel diseases such as Crohn's disease, psoriasis, irritable bowel syndrome, and colitis; diabetes; autoimmune disease; cancer; kidney conditions; and arthritis.

As the prevalence of chronic diseases is increasing at a high rate, the demand for bioproduction in treating life-threatening illnesses has progressed rapidly over the last five years, thereby driving the bioproduction market.

Europe Bioproduction Market Overview

The Europe bioproduction market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Europe occupies a significant position in the global bioproduction market and is estimated to register a notable CAGR during 2022-2030. The increasing prevalence of chronic disorders has resulted in a growing number of product launches and approvals, along with technological advancements and investment, thereby contributing to the market growth in the region.

Biosimilars introduce competition and increase the affordability of biologics, which ultimately deliver savings and value-added services to support patient care and the healthcare industry. Healthcare professionals can treat more patients with high-quality biologics at reduced cost. Due to the massive potential for cost savings, the German Health Ministry introduced a new law to increase the adoption of biosimilars. As a few European Union (EU) countries allow pharmacist substitution of biosimilars, this would represent a significant change in practice, particularly for Germany. In addition, healthcare providers such as PHI Orthopedic Physiotherapy Center, German International Clinic, Frankfurt, Germany; CBC Health Munich, Germany; and other providers offer stem cell therapy for various chronic diseases such as diabetic retinopathy, optic nerve neuritis, and rheumatoid arthritis. This is expected to increase the adoption of cell therapies in the coming years. Also, a growing number of partnerships among international players boost the market growth. For instance, in November 2020, Hitachi Chemical Advanced Therapeutics Solutions, LLC and apceth Biopharma GmbH expanded their relationship with bluebird bio with long-term development and manufacturing services agreements for clinical and commercial supply for multiple therapies, including expanded commercial drug product manufacturing capacity in Europe for ZYNTEGLO, a one-time gene therapy for transfusion-dependent B-thalassemia (TDT). Therefore, with the growing government initiatives for adopting biosimilars in Germany, the market is expected to flourish.

Europe Bioproduction Market Revenue and Forecast to 2030 (US$ Million)

Europe Bioproduction Market Segmentation

The Europe bioproduction market is categorized into product, application, equipment, end user, and country.

Based on product, the Europe bioproduction market is segmented into biologics and biosimilars, vaccines, cell and gene therapies, nucleic acid therapeutics, and others. The biologics and biosimilars segment held the largest Europe bioproduction market share in 2022.

In terms of application, the Europe bioproduction market is segmented into rheumatoid arthritis, hematological disorders, cancer, diabetes, cardiovascular diseases, and others. The cancer segment held the largest Europe bioproduction market share in 2022.

By equipment, the Europe bioproduction market is divided into upstream equipment, downstream equipment, bioreactors, and consumables and accessories. The consumables and accessories segment held the largest Europe bioproduction market share in 2022.

In terms of end user, the Europe bioproduction market is categorized into biopharmaceutical companies, contract manufacturing organizations, and others. The biopharmaceutical companies segment held the largest Europe bioproduction market share in 2022.

By country, the Europe bioproduction market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe bioproduction market share in 2022.

Lonza Group AG, bbi-biotech GmbH, Danaher Corp, Sartorius AG, FUJIFILM Irvine Scientific Inc, Thermo Fisher Scientific Inc, Merck KGaA, F. Hoffmann-La Roche Ltd, and Bio-Rad Laboratories Inc. are some of the leading companies operating in the Europe bioproduction market.

Table of Content

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Bioproduction Market - Key Industry Dynamics

4.1 Market Drivers
- 4.1.1 Rising Adoption of Regenerative Medicines
- 4.1.2 Increasing Prevalence of Chronic Diseases
4.2 Market Restraints
- 4.2.1 High Cost of Cell Therapy and Biosimilar Manufacturing
4.3 Market Opportunities
- 4.3.1 Patent Expiry of Blockbuster Biologics
4.4 Future Trends
- 4.4.1 Shift Toward Automated Cell Therapy Manufacturing
4.5 Impact Analysis

5. Bioproduction Market - Europe Market Analysis

5.1 Europe Bioproduction Market Revenue (US$ Mn), 2020 - 2030

6. Europe Bioproduction Market - Revenue and Forecast to 2030 - by Product

6.1 Overview
6.2 Europe Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
6.3 Biologics and Biosimilars
- 6.3.1 Overview
- 6.3.2 Biologics and Biosimilars: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Vaccines
- 6.4.1 Overview
- 6.4.2 Vaccines: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Cell and Gene Therapies
- 6.5.1 Overview
- 6.5.2 Cell and Gene Therapies: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Nucleic Acid Therapeutics
- 6.6.1 Overview
- 6.6.2 Nucleic Acid Therapeutics: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.7 Others
- 6.7.1 Overview
- 6.7.2 Others: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Bioproduction Market - Revenue and Forecast to 2030 - by Application

7.1 Overview
7.2 Europe Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Cancer
- 7.3.1 Overview
- 7.3.2 Cancer: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Cardiovascular Diseases
- 7.4.1 Overview
- 7.4.2 Cardiovascular Diseases: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Rheumatoid Arthritis
- 7.5.1 Overview
- 7.5.2 Rheumatoid Arthritis: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Hematological Disorders
- 7.6.1 Overview
- 7.6.2 Hematological Disorders: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Diabetes
- 7.7.1 Overview
- 7.7.2 Diabetes: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.8 Others
- 7.8.1 Overview
- 7.8.2 Others: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Bioproduction Market - Revenue and Forecast to 2030 - by Equipment

8.1 Overview
8.2 Europe Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
8.3 Consumables and Accessories
- 8.3.1 Overview
- 8.3.2 Consumables and Accessories: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Downstream Equipment
- 8.4.1 Overview
- 8.4.2 Downstream Equipment: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Bioreactors
- 8.5.1 Overview
- 8.5.2 Bioreactors: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.5.2.1 Europe: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
8.6 Upstream Equipment
- 8.6.1 Overview
- 8.6.2 Upstream Equipment: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Bioproduction Market - Revenue and Forecast to 2030 - by End User

9.1 Overview
9.2 Europe Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Biopharmaceutical Companies
- 9.3.1 Overview
- 9.3.2 Biopharmaceutical Companies: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Contract Manufacturing Organizations
- 9.4.1 Overview
- 9.4.2 Contract Manufacturing Organizations: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Others
- 9.5.1 Overview
- 9.5.2 Others: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Bioproduction Market - Revenue and Forecast to 2030 - Country Analysis

10.1 Europe: Bioproduction Market
- 10.1.1 Europe: Bioproduction Market, by Country, 2022 & 2030 (%)
  - 10.1.1.1 Germany: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.1.1 Germany: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.1.2 Germany: Bioproduction Market, by Product, 2020-2030 (US$ Million)
    - 10.1.1.1.3 Germany: Bioproduction Market, by Application, 2020-2030 (US$ Million)
    - 10.1.1.1.4 Germany: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.1.4.1 Germany: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.1.5 Germany: Bioproduction Market, by End User, 2020-2030 (US$ Million)
  - 10.1.1.2 UK: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.2.1 Overview
    - 10.1.1.2.2 UK: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.2.3 UK: Bioproduction Market, by Product, 2020-2030 (US$ Million)
    - 10.1.1.2.4 UK: Bioproduction Market, by Application, 2020-2030 (US$ Million)
    - 10.1.1.2.5 UK: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.2.5.1 UK: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.2.6 UK: Bioproduction Market, by End User, 2020-2030 (US$ Million)
  - 10.1.1.3 France: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.3.1 Overview
    - 10.1.1.3.2 France: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.3.3 France: Bioproduction Market, by Product, 2020-2030 (US$ Million)
    - 10.1.1.3.4 France: Bioproduction Market, by Application, 2020-2030 (US$ Million)
    - 10.1.1.3.5 France: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.3.5.1 France: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.3.6 France: Bioproduction Market, by End User, 2020-2030 (US$ Million)
  - 10.1.1.4 Italy: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.4.1 Overview
    - 10.1.1.4.2 Italy: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.4.3 Italy: Bioproduction Market, by Product, 2020-2030 (US$ Million)
    - 10.1.1.4.4 Italy: Bioproduction Market, by Application, 2020-2030 (US$ Million)
    - 10.1.1.4.5 Italy: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.4.5.1 Italy: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.4.6 Italy: Bioproduction Market, by End User, 2020-2030 (US$ Million)
  - 10.1.1.5 Spain: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.5.1 Overview
    - 10.1.1.5.2 Spain: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.5.3 Spain: Bioproduction Market, by Product, 2020-2030 (US$ Million)
    - 10.1.1.5.4 Spain: Bioproduction Market, by Application, 2020-2030 (US$ Million)
    - 10.1.1.5.5 Spain: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.5.5.1 Spain: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.5.6 Spain: Bioproduction Market, by End User, 2020-2030 (US$ Million)
  - 10.1.1.6 Rest of Europe: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.6.1 Overview
    - 10.1.1.6.2 Rest of Europe: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.6.3 Rest of Europe: Bioproduction Market, by Product, 2020-2030 (US$ Million)
    - 10.1.1.6.4 Rest of Europe: Bioproduction Market, by Application, 2020-2030 (US$ Million)
    - 10.1.1.6.5 Rest of Europe: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.6.5.1 Rest of Europe: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.6.6 Rest of Europe: Bioproduction Market, by End User, 2020-2030 (US$ Million)

11. Bioproduction Market-Industry Landscape

11.1 Overview
11.2 Growth Strategies in the Bioproduction Market
11.3 Inorganic Growth Strategies
- 11.3.1 Overview
11.4 Organic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 . Lonza Group AG
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 bbi-biotech GmbH
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Danaher Corp
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Sartorius AG
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 FUJIFILM Irvine Scientific Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Thermo Fisher Scientific Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Merck KGaA
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 F. Hoffmann-La Roche Ltd
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Bio-Rad Laboratories Inc
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. Europe Bioproduction Market Segmentation
Table 2. Europe Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 3. Germany Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 4. Germany Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 5. Germany Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 6. Germany Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 7. Germany Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 8. UK Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 9. UK Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 10. UK Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 11. UK Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 12. UK Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 13. France Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 14. France Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 15. France Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 16. France Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 17. France Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 18. Italy Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 19. Italy Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 20. Italy Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 21. Italy Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 22. Italy Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 23. Spain Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 24. Spain Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 25. Spain Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 26. Spain Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 27. Spain Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 28. Rest of Europe Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 29. Rest of Europe Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 30. Rest of Europe Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 31. Rest of Europe Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 32. Rest of Europe Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 33. Recent Inorganic Growth Strategies in the Bioproduction Market
Table 34. Recent Organic Growth Strategies in the Bioproduction Market
Table 35. Glossary of Terms, Bioproduction Market

List Of Figures

Figure 1. Europe Bioproduction Market Segmentation, By Country
Figure 2. Europe Bioproduction Market: Key Industry Dynamics
Figure 3. Europe Bioproduction Market: Impact Analysis of Drivers and Restraints
Figure 4. Europe Bioproduction Market Revenue (US$ Mn), 2020 - 2030
Figure 5. Europe Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
Figure 6. Biologics and Biosimilars: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Vaccines: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Cell and Gene Therapies: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Nucleic Acid Therapeutics: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Others: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Europe Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
Figure 12. Cancer: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Cardiovascular Diseases: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Rheumatoid Arthritis: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Hematological Disorders: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Diabetes: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Europe Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
Figure 19. Consumables and Accessories: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Downstream Equipment: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Bioreactors: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Upstream Equipment: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Europe Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
Figure 24. Biopharmaceutical Companies: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Contract Manufacturing Organizations: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Others: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Europe: Bioproduction Market, by Key Country - Revenue (2022) (US$ Million)
Figure 28. Europe: Bioproduction Market, by Country, 2022 & 2030 (%)
Figure 29. Germany: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 30. UK: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. France: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. Italy: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 33. Spain: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 34. Rest of Europe: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 35. Growth Strategies in the Bioproduction Market